background: Whereas studies have revealed that the cryopreservation of human semen increases sperm DNA fragmentation, the mechanisms involved in this type of cryo-injury are largely unknown. Elucidation of these mechanisms may provide insight into preventing such injury. results: Cryopreservation led to a significant increase in percentage DNA fragmentation, percentage 8OHdG and percentage caspase positive cells (P , 0.001). Percentage DNA fragmentation was positively correlated with percentage 8OHdG before (r ¼ 0.756, P , 0.001) and after cryopreservation (r ¼ 0.528, P ¼ 0.017). The addition of 50 and 100 mM genistein to the cryoprotectant had a significant protective effect on sperm DNA (P , 0.001) although the caspase inhibitor demonstrated no difference to the control.
Introduction
The cryopreservation of human semen is an important procedure used regularly for different purposes, including donor insemination and the preservation of gametes from patients undergoing chemotherapy (Cavalla et al., 2006; Anderson, 2008 ). An optimal method of performing such a procedure however, remains elusive. The general composition of the cryoprotectant media available for semen/sperm cryopreservation in particular has remained unchanged for many years. This is in stark contrast to the media available for embryo and oocyte cryopreservation, which is constantly the subject of new research.
In addition to the well-documented effects of cryopreservation on the fertilization capacity, motility, morphology and viability of spermatozoa (Nallella et al., 2004) , cryopreservation has also been revealed to both generate and exacerbate the extent of sperm DNA fragmentation in infertility patients (Hammadeh et al., 1999; Donnelly et al., 2001; de Paula et al., 2006; Thomson et al., 2008 Thomson et al., , 2009 ). The impact of sperm DNA fragmentation on achieving pregnancy either naturally or through assisted reproduction technology (ART) treatment has been well discussed Benchaib et al., 2003 Benchaib et al., , 2007 Seli et al., 2004; Borini et al., 2006) and the possible consequences of achieving a pregnancy using sperm possessing DNA damage is a concern (Lewis and Aitken, 2005) . Despite this, the exact mechanisms involved in the aetiology of sperm DNA fragmentation including the cause of cryo-injury to sperm DNA have yet to be fully elucidated. Such mechanisms warrant further investigation in order to provide a basis for the development of new cryoprotectant media.
Apoptosis may play a role in cryo-injury to sperm DNA as the process of cryopreservation has been shown to increase the activation of particular aspartic acid-directed cysteine proteases, called caspases, in both human (Paasch et al., 2004b; Wundrich et al., 2006) and bull spermatozoa (Martin et al., 2004) . Caspases, particularly caspases 1, 3, 8 and 9, are known to play a key role in the cellular apoptotic cascade and eventual cell death (Thornberry and Lazebnik, 1998) . Apoptosis is a natural process that occurs throughout spermatogenesis but abortive apoptosis, in which the cells are not completely destroyed following the induction of DNA fragmentation by endonucleases, has been implicated in the generation of sperm exhibiting DNA damage in the ejaculate (Sakkas et al., 2003) . Although there are some reports of a correlation between the presence of activated caspases and sperm DNA fragmentation (Weng et al., 2002; Marchetti et al., 2004) , the results are far from compelling, and there is not as yet any strong evidence to suggest a caspase/apoptosis-related increase in sperm DNA fragmentation during cryopreservation (Martin et al., 2004; Paasch et al., 2004b) .
Oxidative stress represents another potential mechanism by which DNA fragmentation can be induced in spermatozoa (Aitken et al., 2009) and as the process of cryopreservation does seem to increase the level of reactive oxygen species (ROS) generation in spermatozoa (Mazzilli et al., 1995; Wang et al., 1997) , it is possible that oxidative stress is also responsible for cryo-injury to sperm DNA. Many studies have reported a link between sperm DNA fragmentation and ROS (Irvine et al., 2000; Baumber et al., 2003; Peris et al., 2007) but oxidative base damage and its association with sperm DNA fragmentation has not been extensively investigated. Human spermatozoa in particular are known to produce the superoxide anion (De Iuliis et al., 2006) which is capable of dismutating either spontaneously or enzymatically to hydrogen peroxide (H 2 O 2 ) (Alvarez et al., 1987) . Due to its high oxidant activity and ability to cross membranes, H 2 O 2 is considered particularly cytotoxic (Alvarez et al., 1987) . Superoxide and H 2 O 2 can also form the extremely noxious hydroxyl radical which is capable of attacking almost every cellular component (de Lamirande et al., 1997) . Seminal plasma and, to some extent, spermatozoa contain enzymatic and non-enzymatic antioxidants to help protect them from such oxidative attack (van Overveld et al., 2000) . However, oxidative stress is created when the cellular generation of ROS overwhelms these antioxidant defences and this may occur during cryopreservation.
In light of these considerations, it is important to ascertain whether the observed increase in DNA fragmentation following cryopreservation is due to an increase in the activation of an intrinsic apoptotic cascade or to an increase in ROS and oxidative stress. Using this information it may be possible to improve the cryoprotectant media that is currently available.
Materials and Methods

Collection of semen samples
This study was approved by the Fertility First Institutional Review Board, and informed consent was obtained from each patient. Sixty semen samples were obtained from 60 patients experiencing fertility issues who presented for assessment of sperm DNA fragmentation following a recommended period (2 -7 days) of sexual abstinence. Twenty semen samples were used for each of three separate experiments; comparison of percentage sperm DNA fragmentation, percentage 8-oxo-7,8-dihydro-2 0 deoxyguanosine (8OHdG) and percentage caspase positive cells before and after cryopreservation; effect of the estrogenic compound genestein on cryo-injury to sperm DNA; and the effect of a caspase inhibitor on cryo-injury to sperm DNA. Patients were recruited in blocks of 20 as each experiment was performed consecutively.
Semen analysis
Semen analysis was performed according to the World Heath Organization (WHO) guidelines (WHO, 1999) using light microscopy. Concentration was determined in duplicate using a haemocytometer (Improved Neubauer, Weber, England), motility was determined using four categories of movement; fast progressive, slow progressive, nonprogressive and immotile and morphology using Diff-Quik (Fronine, Sydney, Australia) stain and the WHO criteria for morphology with .14% normal sperm considered normal. Vitality was assessed using eosin red stain.
Preparation of stock solutions
Genistein
The estrogenic compound genistein from soybean (Sigma-Aldrich, Missouri, USA) was initially dissolved in dimethyl sulphoxide (DMSO) (Sigma-Aldrich, Missouri, USA) to yield a 10 mM stock solution. This solution was frozen in aliquots and stored at 2208C until use. A 1 mM working solution was prepared at the time of use with Quinn's Advantagew Medium with HEPES (QAMH) (SAGE In-Vitro Fertilization Inc, Connecticut, USA). The final concentrations of DMSO in the samples treated with 50 and 100 mM genistein were 0.5 and 1.0%, respectively.
Caspase inhibitor
The cell permeable pan-caspase inhibitor Z-VAD(OMe)-FMK (Merck, Darmstadt, Germany) was initially dissolved in DMSO to yield a 10 mM stock solution. This solution was frozen in aliquots and stored at 2208C until use. A 1 mM working solution was prepared at the time of use with QAMH. The final concentration of DMSO in samples treated with the caspase inhibitor was 0.5%.
Semen preparation
Following liquefaction a portion of each semen sample was prepared for assessment of sperm DNA fragmentation (n ¼ 60), percentage 8OHdG (n ¼ 60) and percentage caspase positive cells (n ¼ 20) both with and without prior density gradient centrifugation (DGC), another portion used for semen analysis and the remainder of each crude sample split into separate aliquots for cryopreservation.
In the genistein experiment (n ¼ 20), one aliquot was diluted 1:1 with Quinn's Advantage w Sperm Freeze (QASF; SAGE In-Vitro Fertilization Inc.) medium according to the manufacturer's instructions. The second and third aliquots were diluted 1:1 with QASF medium supplemented with genistein to yield final concentrations of 50 and 100 mM, respectively. These concentrations of genistein were chosen based on findings reported in a study detailing the potential antioxidant properties of this particular estrogenic compound at concentrations below 200 mM (Bennetts et al., 2008) . The final aliquot was diluted 1:1 with QASF medium supplemented with the vehicle for genistein, DMSO, at the final concentration of 1%.
In the caspase inhibitor experiment (n ¼ 20), one aliquot was diluted 1:1 with QASF medium according to the manufacturer's instructions. A second aliquot was diluted 1:1 with QASF medium supplemented with the caspase inhibitor Z-VAD(OMe)-FMK to yield a final concentration of 100 mM. A DMSO control sample was not included in this experiment as it was found that 1% DMSO had no effect on motility, vitality, DNA fragmentation or 8OHdG in the genistein experiment.
To fractionate the semen samples, a layer of 200 -1000 ml of a portion of each fresh or thawed semen sample was applied to a 45%:90% Percoll (GE Healthcare, Uppsala, Sweden) density gradient and centrifuged at 500 Â g for 20 min to obtain a progressively motile sperm subpopulation. This initial semen preparation procedure was performed to ensure that the sperm being examined were from the same subpopulation of sperm that would be used for treatment in ART. The lower fraction was collected and twice re-suspended in phosphate buffered saline (PBS) and centrifuged at 500 Â g for 10 min. The portion of the sample not requiring DGC was simply twice re-suspended in PBS and centrifuged at 500 Â g for 10 min.
Cryopreservation and thawing of spermatozoa
Once prepared, all samples were loaded into de-identified 0.5 ml Cassou straws (IMV Technologies, L'Aigle, France) and sealed with Stopping Powder (IMV Technologies). All straws were frozen using a Kryo 10 Series III programmable freezer (Planer Products, Middlesex, UK). The program commenced with a chamber temperature of 208C and decreased at a rate of 68C per minute to a final holding temperature of 2808C. At completion of the freezing program the straws were removed and stored in liquid nitrogen. Samples were removed from storage in batches and thawed at room temperature. In line with the protocols of this laboratory, media was not added during thawing.
Assessment of sperm DNA fragmentation
Assessment of sperm DNA fragmentation was performed using the terminal deoxynucleotidyl transferase (TdT)-mediated deoxyuridinetriphosphate (dUTP) nick-end labelling (TUNEL) assay as described previously (Thomson et al., 2008) with procedures performed in duplicate. The TUNEL assay is a direct measure of sperm DNA damage and is based on the addition of fluorescence-labelled nucleotides, namely deoxyuridine, on free 3 0 -OH ends of DNA breaks in a reaction catalyzed by the TdT enzyme. Slides were stained with fluorescein isothiocyanate (FITC)-labelled dUTP (Roche, Mannheim, Germany) and counterstained with propidium iodide (PI) to enable identification of sperm nuclei. Images were captured using IP Lab software (IP Lab v3.7, Scanalytics Inc, Fairfax, USA). The total number of sperm was determined from the PI image before superimposing the FITC and PI images to identify TUNEL positive cells. A minimum of 200 spermatozoa was assessed in all cases.
Positive and negative control slides were included in each run of the TUNEL assay. The positive control slide was incubated with DNAse solution for 30 min in the dark to induce DNA damage prior to the addition of TUNEL reagents. The negative control was treated in the same manner as the positive control slide, however, TdT was not included in the TUNEL reaction for this slide.
Assessment of oxidative DNA damage
The percentage of spermatozoa possessing oxidative damage to their DNA was assessed using 8OHdG as the marker and performed as described previously (Kao et al., 2008) with some alterations. This assay allows for the detection of 8OHdG in sperm cells via the use of a FITC-labelled 8OHdG-specific protein available commercially in the OxyDNA Test Kit (Biotrin, Dublin, Ireland).
The initial procedures were the same as for the TUNEL assay described above. After permeabilization however, slides were incubated with FITCconjugate solution at room temperature for 1 h in the dark. The remainder of the assay, including counterstaining with PI was performed as for the TUNEL assay. Positive and negative controls were also included in each run of the 8OHdG assay. The positive control tube was incubated with H 2 O 2 at 378C for 6 min to induce oxidative DNA damage prior to smearing the pellet on to a poly-L-lysine slide for drying. As a negative control, PBS only was added to the smear region on the negative control slide.
Assessment of apoptosis
The percentage of spermatozoa undergoing apoptosis was assessed via the determination of the percentage of cells possessing activated caspases. This was achieved through the use of a fluorescence-labelled caspase inhibitor supplied in the commercially available FLICA TM (Fluorochrome Inhibitor of Caspases) Apoptosis Detection Kit's Caspase Assay pack for Poly-caspase detection (AbD Serotec, Oxford, UK). The FLICA TM reagent in this kit is a carboxyfluorescein derivative of a cell permeable caspase inhibitor peptide, valylalanylaspartic acid-fluoromethyl ketone (VAD-FMK) which exhibits green fluorescence. The labelled inhibitor sequence permeates the cell and binds covalently to a reactive cysteine residue on its target activated caspase(s) within that cell, trapping the fluorochrome within the cells and thus providing details of the number of cells within a population which show signs of activating their apoptotic machinery (Paasch et al., 2004a) .
This assay was performed as per the manufacturer's instructions and as previously described (Marchetti et al., 2004) with some alterations. During protocol design for this assay, it was observed that a large number of sperm were losing their motility and/or dying during the incubation stages. A comparison was done to determine whether cell survival could be improved by using the same density gradient used in the clinical laboratory, which in this case was Sydney IVF Spermient (Cook, Eight Mile Plains, Australia). Cell survival was greatly improved using this medium and 45 and 90% solutions were prepared by diluting the Spermient in QAMH. The TUNEL and 8OHdG assays were then performed on a sample using both Percoll and Spermient as the density gradient media to ensure that there were no differences. No differences were identified between these two methods in terms of percentage DNA fragmentation or percentage oxidative DNA damage but cell survival was much improved. It was thus decided to use Spermient gradient rather than Percoll gradient preparations for the caspase assay.
HEPES medium supplemented with 5% Human Serum Albumin (SAGE In-Vitro Fertilization Inc.) was used for this assay instead of PBS in order to provide further support for the sperm cells during the various incubations and ensure cell survival for activated caspase detection. The resulting pellets were re-suspended in fresh medium to a final concentration of approximately 2 million/ml in a volume of !300 ml. The suspensions were then incubated with the FLICA TM reagent at 378C for 30 min in the dark. Following incubation, the suspensions were twice re-suspended in wash buffer supplied with the FLICA TM kit and centrifuged at 350 Â g for 5 min. The suspensions were again re-suspended in a final volume of 300 ml and fixative solution, also supplied with the FLICA TM kit, was added to each tube and gently mixed before incubating at room temperature for 15 min in the dark. An aliquot of 15 ml of cell suspension was then smeared on to two polylysine slides and allowed to air dry in the dark. Finally, smears were covered and examined using both light and fluorescence microscopy. Images were captured using IP Lab software. The total number of sperm was determined from a phase contrast image before superimposing the FLICA TM and phase contrast images to identify caspase positive cells. A minimum of 200 spermatozoa was assessed in all cases.
Positive and negative controls were also included in each run of the caspase assay. The positive control tube was incubated at 568C for 5 -10 min to induce apoptosis prior to adding the FLICA TM reagent. As a negative control, wash buffer only was added to the negative control suspension.
Statistical analysis
All statistical analyses utilized the Statistical Package for the Social Sciences (SPSS 15.0 for Windows, Chicago, USA). Spearman's rank correlation was used to quantify the pairwise associations between continuous variables of interest. Repeated measures analysis of variance (ANOVA) (GreenhouseGeisser method) was used to test for treatment effect. Where a significant effect was detected, post-hoc pairwise comparisons were used to identify which particular treatments differed significantly. All analyses were exploratory and a significance level of 0.05 was used throughout. Differences in the means were established using paired t tests.
All samples were assessed for percentage sperm DNA fragmentation, percentage 8OHdG and percentage caspase positive cells by a single scientist. A single semen sample was frozen as 10 separate aliquots and thawed separately over a period of 5 weeks to determine inter-assay variability. The mean percentage sperm DNA fragmentation of the samples for assessment of inter-assay variation was 64.4% and the standard deviation was 1.506. This gives a coefficient of variation of 2.3%. The mean percentage 8OHdG of the samples for assessment of inter-assay variation was 8.0% and the standard deviation was 0.079. This gives a coefficient of variation of 1.0%. The mean percentage caspase positive cells in the samples for assessment of inter-assay variation was 11.1% and the standard deviation was 0.095. This gives a coefficient of variation of 0.9%. All differences were negligible.
Results
Characteristics of the study population
The mean age of the 60 subjects was 38.2 years with a range of 28 -50 years. Age was found to have no effect on any of the parameters in the study. The mean length of sexual abstinence was 3.1 days with a range of 0-7 days. Four patients had abstained for less than the recommended number of days prior to sample collection. Removing these patients had no affect on the results. Thirty-four (57%) of the men were found to have an abnormal semen analysis but none had severe asthenozoospermia or oligozoospermia. Samples were frozen an average of 76 min after collection and spent an average of 14 days in storage prior to thawing. The mean percentage sperm DNA fragmentation in unfractionated semen was 10.2 and 13.3% in the high density fraction (P , 0.01), the mean percentage 8OHdG was 20.9% in unfractionated semen and 18.9% in the high density fraction [non significant (NS)] and the mean percentage caspase positive cells was 20.4 and 12.4% in unfractionated and fractionated semen, respectively (P , 0.01).
Experiment one: comparison of percentage sperm DNA fragmentation, oxidative base damage and caspase activation in sperm cells before and after cryopreservation Relationship between DNA fragmentation, 8OHdG and caspase activation in fresh semen
Prior to separation, percentage sperm DNA fragmentation was found to be highly positively correlated with percentage 8OHdG (r ¼ 0.756, P , 0.001). The same correlation was found between these two parameters in the high density fraction (r ¼ 0.568, P , 0.01). A highly positive correlation was also identified between percentage sperm DNA fragmentation and percentage caspase positive cells in the separated samples (r ¼ 0.711, P , 0.001). Both the mean percentage sperm DNA fragmentation and mean percentage 8OHdG were higher in those patients with an abnormal semen analysis (7.4 versus 12.4%, P , 0.01 and 15.2 versus 25.2%, P , 0.001, respectively). There were no differences between those with a normal and abnormal semen analysis in terms of caspase activation (20.7 versus 20.2%, NS).
Effect of cryopreservation on sperm DNA fragmentation, 8OHdG and caspase positive cells Cryopreservation resulted in a significant increase in percentage sperm DNA fragmentation, percentage 8OHdG and percentage caspase positive cells (Fig. 1) . Separation using DGC was unable to subsequently reduce these increases, with no significant differences between any of the separated and non-separated post-thaw pairs.
Relationship between sperm DNA fragmentation, 8OHdG and caspase positive cells following cryopreservation
The percentage sperm DNA fragmentation was found to be positively correlated with percentage 8OHdG following cryopreservation and separation using DGC (r ¼ 0.528, P , 0.05). The correlation between these two parameters did not reach significance in the unfractionated samples (r ¼ 0.414, P ¼ 0.07). The degree to which percentage sperm DNA fragmentation and percentage 8OHdG increased was also positively correlated in both the unfractionated (r ¼ 0.486, P , 0.05) and fractionated samples (r ¼ 0.656, P , 0.01). A negative correlation was identified between the percentage of caspase positive cells and percentage sperm DNA fragmentation in unfractionated samples only (r ¼ 2 0.455, P , 0.05).
Experiment two: effect of the estrogenic compound genistein on cryo-injury to sperm DNA The addition of both 50 and 100 mM genistein to QASF medium prior to cryopreservation had a significant protective effect on sperm DNA in terms of the percentage sperm DNA fragmentation in the high density fraction (P , 0.001) and the unfractionated ejaculate (P , 0.05), and the percentage 8OHdG in the high density fraction (P , 0.01) and the unfractionated ejaculate (P , 0.01) (Fig. 2) post-thaw using repeated measures ANOVA. Furthermore, with the addition of 100 mM genistein to the cryoprotective medium, both the percentage sperm DNA fragmentation (12.2 versus 14.8%, NS) and percentage 8OHdG (20.8 versus 24.6%, NS) in the high density fraction remained unchanged following cryopreservation. The percentage sperm DNA fragmentation in the high density fraction also remained unchanged with the addition of 50 mM genistein (12.2 versus 15.9%, NS) but percentage 8OHdG was slightly higher (20.8 Versus 25.4%, P , 0.05). The concentrations of genistein used also had a significant effect on post-thaw motility (P , 0.001) and vitality (P , 0.001) using repeated measures but only the samples containing 100 mM genistein demonstrated a significantly higher vitality post-thaw (P , 0.001) (Fig. 2) . The vehicle for genistein, DMSO, had no effect on the percentage sperm DNA fragmentation, percentage 8OHdG, motility or vitality as compared with the untreated sample (P . 0.05 in all cases).
Experiment three: effect of a caspase inhibitor on cryo-injury to sperm DNA The supplementation of QASF medium with 100 mM of the pancaspase inhibitor Z-VAD(OMe)-FMK had no protective effect on sperm DNA in terms of the percentage sperm DNA fragmentation or percentage 8OHdG in either the high density fraction or the unfractionated ejaculate post-thaw using repeated measures ANOVA (Fig. 3) . Likewise, no protective effect offered by the caspase inhibitor was observed in terms of post-thaw motility or vitality (Fig. 3) .
Discussion
We found that the process of cryopreservation resulted in an increase in DNA fragmentation, oxidative base damage and caspase activation in human sperm. These increases were apparent not only in the unfractionated samples but also in the high density fractions obtained following DGC. This suggests that DNA damage, oxidative stress and caspase activation induced by cryopreservation are a feature of the high quality sperm isolated by density gradients and not simply the result of poor quality cells exhibiting vulnerability. The fact that the number of apoptotic cells could be reduced using DGC in fresh semen but not frozen-thawed semen implies that the cryopreserved sperm were in a relatively early stage of apoptosis. Longer incubation periods post-thaw and prior to DGC may enable these cells to complete apoptosis and therefore allow for their subsequent removal.
The increase in percentage sperm DNA fragmentation following cryopreservation has been well documented by ourselves (Thomson et al., 2008 (Thomson et al., , 2009 ) and others (Hammadeh et al., 1999; Donnelly et al., 2001; de Paula et al., 2006) . Many groups have also reported an increase in the percentage of sperm cells possessing activated Figure 1 Effect of cryopreservation on sperm DNA fragmentation, 8OHdG and apoptosis. ***Significantly different to pre-freeze result (P , 0.001), bars represent +1 SE.
Cryopreservation and sperm DNA fragmentation caspases (Martin et al., 2004; Paasch et al., 2004b; Wundrich et al., 2006) but ours is only the second study to demonstrate an increase in the percentage of oxidative DNA damage as determined using 8OHdG as a biomarker of oxidative stress (Zribi et al., 2008) .
Other groups have however, demonstrated an increase in ROS following cryopreservation (Mazzilli et al., 1995; Wang et al., 1997) and so our results further allude to a cryopreservation-induced increase in oxidative stress in human spermatozoa.
Of most interest is the relationship between sperm DNA fragmentation and oxidative DNA damage. These two parameters, which were highly correlated in fractionated and unfractionated fresh semen, remained positively correlated following cryopreservation and separation via DGC. Although the correlation did not quite reach significance prior to DGC in the group of 20 patients in experiment one, significance was reached when results from all 60 patients were analysed together (r ¼ 0.539, P , 0.001). This finding is in disagreement with a previous report (Zribi et al., 2009) but that study only recruited 15 subjects and this discrepancy is therefore most likely the result of the relatively low sample size in their study. Our results indicate that the mechanism that generates and exacerbates sperm DNA fragmentation during cryopreservation also generates and exacerbates oxidative damage to sperm DNA to the same extent.
It is interesting that we found that DNA fragmentation could not be reduced by DGC. This is consistent with one report (Stevanato et al., 2008) but inconsistent with others (Donnelly et al., 2000b; Morrell et al., 2004) . The same observation was made for percentage 8OHdG. We did find that some patients demonstrated a decrease in sperm DNA damage following DGC but the overall increase observed is possibly the result of an anomaly in the group of patients studied. It is possible that some patients have a large number of dead or poorly motile sperm that do not possess fragmented DNA or oxidative base damage and therefore the removal of these sperm would not alter, and may even increase, the percentage of sperm possessing DNA damage observed following DGC. Similarly, some patients may possess a large number of 'good quality' sperm in the high density fraction that possess fragmented DNA. In support of this, many other studies have demonstrated high levels of DNA fragmentation in highly motile sperm (Seli et al., 2004; Huang et al., 2005; Benchaib et al., 2007) .
Genistein is a naturally occurring phyto-estrogen found in relatively high concentrations in soybeans (Zielonka et al., 2003) and has recently been reported to be a potential antioxidant in a study using spermatozoa (Bennetts et al., 2008) . It has also been shown to not only provide protection to cells from oxidative stress and lipid peroxidation but also to reduce the resultant DNA fragmentation (Liang Figure 2 The effect of genistein supplementation of QASF medium on (A) sperm DNA fragmentation, (B) 8OHdG and (C) motility and vitality post-thaw. Bars represent +1 SE, *Significantly different to untreated sample (P 0.05), **Significantly different to untreated sample (P 0.01), ***Significantly different to untreated sample (P 0.001),^Significantly different to fresh sample (P 0.05),^^Significantly different to fresh sample (P 0.01),^^^Significantly different to fresh sample (P 0.001).
et al., 2008). We found genistein to be effective at reducing the level of DNA fragmentation and oxidative damage during cryopreservation. These findings suggest that damage to human sperm DNA during cryopreservation is generated by an increase in oxidative stress. The fact that the samples treated with genistein also exhibited higher motility and vitality post-thaw, supports the link between oxidative stress, DNA damage and general function in human spermatozoa. Our findings are consistent with previous studies demonstrating the benefits of supplementing sperm preparation media with enzymatic and non-enzymatic antioxidants (Tremellen, 2008) . Glutathione and hypotaurine have been found to protect against DNA damage induced by H 2 O 2 (Donnelly et al., 2000a) and vitamins C and E have been shown to exhibit a protective effect on sperm DNA when used during the preparation of sperm for use in ART (Hughes et al., 1998; Donnelly et al., 1999) . Reports on the addition of antioxidants to human cryopreservation media are scarce but one study found that both vitamin C and catalase are capable of reducing ROS generation during cryopreservation (Li et al., 2007) and another showed that vitamin E supplementation was able to improve post-thaw motility but was unable to improve DNA integrity or sperm viability (Taylor et al., 2009) . The current study is the first study to identify an estrogenic compound that is not only capable of reducing cryopreservation-induced DNA damage to human spermatozoa, but also of improving post-thaw motility and vitality, when added to the cryoprotectant media.
Genistein inhibits enzymes capable of generating ROS, such as xanthine oxidase (Wei et al., 1995) and possesses the ability to scavenge peroxyl radicals and inhibit lipid peroxidation (Zielonka et al., 2003) . In addition to scavenging ROS within cells, genistein has been shown to enhance the activity of endogenous antioxidants such as glutathione peroxidase, glutathione reductase and superoxide dismutase (Wei et al., 1995) , all enzymes which are present in human spermatozoa (Alvarez et al., 1987; Alvarez and Storey, 1989) . This molecule has also been reported to exhibit anti-mutagenic activity (Miyazawa et al., 1999) and to inhibit the induction of DNA fragmentation by ROS in plasmid DNA (Win et al., 2002) . Therefore, genistein probably acts via several different mechanisms to reduce the generation and exacerbation of cryopreservation-induced sperm DNA fragmentation. One possible Figure 3 The effect of the addition of a caspase inhibitor to QASF medium on (A) sperm DNA fragmentation, (B) 8OHdG and (C) motility and vitality post-thaw. Bars represent +1 SE,^^Significantly different to fresh sample (P 0.01),^^^Significantly different to fresh sample (P 0.001).
issue with genistein however, is that it has been shown to inhibit protein tyrosine kinase and therefore protein phosphorylation (Huang et al., 1992) , a process known to be important for sperm function (Aitken et al., 1995) and the process of capacitation in particular (Aitken, 1997) . It would therefore be prudent to assess the effect of genistein on such processes prior to its inclusion in cryoprotectant media.
In the fresh samples, percentage sperm DNA fragmentation was also highly positively correlated with the percentage of cells exhibiting activated caspases, but this correlation occurred in the high density fraction only which is consistent with a report by Marchetti et al. (2004) . Following cryopreservation however, these two parameters were actually negatively correlated and the degree to which they increased was likewise negatively correlated. It is interesting that the correlation between apoptosis and DNA fragmentation in fresh semen is only evident in the high density fraction of semen. It implies that the apoptotic, but still highly motile and vital, sperm present in this fraction of the ejaculate likely possess fragmented DNA and oxidative damage, whereas a portion of the apoptotic sperm with poor vitality and motility removed via DGC do not possess fragmented DNA. It is logical to assume then that these poor quality sperm may have leaky membranes and as a result, the activation of the apoptotic machinery could perhaps get as far as the activation of caspases but these enzymes, or their endonuclease targets, may escape the cell before fragmentation of nuclear DNA can occur. The removal of these cells via DGC would therefore result in the observed decrease in apoptotic cells but would not affect the overall percentage of sperm with fragmented DNA.
The motile and vital apoptotic sperm present in the high density fraction following DGC that also possess fragmented DNA and oxidative base damage could be explained by concurrent pathways believed to be involved in the generation of sperm DNA fragmentation. These pathways can be seen in Fig. 4 . Several apoptotic stimuli are capable of triggering the transcription of different pro-apoptotic genes, one of which is Bax which encodes the mitochondrial membrane pro-apoptotic Bax protein (Taylor et al., 2004) . This protein is capable of opening the mitochondrial permeability transition pore which results in mitochondrial swelling and the release of cytochrome c (Correa et al., 2007) . The release of cytochrome c into the cytoplasm leads to the activation of caspases which in turn activate specific endonucleases and result finally in the fragmentation of DNA (Taylor et al., 2004) . But, cytochrome c also results in an increase in ROS and therefore can contribute to the second pathway in which endogenous and/or exogenous ROS attack DNA, resulting in the production of 8OHdG and finally the fragmentation of DNA (Cui et al., 2000) .
Given the aforementioned correlations between caspase positive cells and sperm DNA fragmentation, and 8OHdG and sperm DNA fragmentation, it is likely that the generation of DNA fragmentation in fresh semen is due to the concurrent nature of the two pathways (Fig. 4) and may be compounded by additional ROS generated by abnormal spermatozoa.
The negative correlations between sperm DNA damage and caspase activation post-thaw indicates that cryopreservation-induced DNA fragmentation occurs independently of caspase activation and likely occurs in non-apoptotic cells. The increase in percentage caspase positive cells, and therefore apoptotic cells, is more than likely due to insults to the structural integrity of the spermatozoa that occur during cryopreservation. As discussed previously, membrane-compromised apoptotic cells may indeed reach the stage of caspase activation during cryopreservation, as indicated by our results, but the caspases or their endonuclease targets may escape the cells before DNA fragmentation can be initiated. Thus, the predominant pathway to DNA fragmentation operating during cryopreservation is the ROS pathway rather than the apoptotic pathway.
Previous studies have reported that the addition of a caspase inhibitor to cryopreservation media has no effect on the post-thaw motility or viability of canine (Peter and Linde-Forsberg, 2003) or equine spermatozoa (Anonymous, 2005) . We too found that the addition of a caspase inhibitor to the cryoprotectant medium had no effect on the post-thaw motility or viability of human spermatozoa, but we also found that it was incapable of reducing the amount of damage sustained by sperm DNA during the process of cryopreservation. It is therefore likely that the activation of caspases and the process of apoptosis are not responsible for the observed increased in damage to human sperm DNA during cryopreservation.
In conclusion, we have shown that human sperm DNA fragmentation is associated with an increase in oxidative stress during cryopreservation, rather than the activation of caspases and apoptosis. The addition of the estrogenic compound genistein or a similar antioxidant could prove to be an invaluable addition to the cryoprotectant media currently available and such an improvement could go far in reducing the risks of human sperm cryopreservation but further independent studies will be necessary to confirm our findings.
